KIMBERLY JEFFREY: Open Payments
NPI 1730517095 · COTTONWOOD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 33 payments from 17 companies in 2025. Trend: 2023 $200 · 2024 $641 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $156 |
| Xeris Pharmaceuticals, Inc. | 3 | $71 |
| Alexion Pharmaceuticals, Inc. | 3 | $68 |
| Ascendis Pharma Endocrinology Inc | 3 | $62 |
| Alvogen Inc | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $35 |
| ABBVIE INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
Products named: TEPEZZA, GVOKE HYPOPEN, STRENSIQ, Yorvipath, TERIPARATIDE, LEQVIO, EVENITY, Veozah.
Industry payments across AZ — which companies pay providers there.
